Related Experiment Videos
Type IV collagen in normal and diseased glomerular basement membrane
K Tryggvason1, J Zhou, S L Hostikka
1Department of Biochemistry, University of Oulu, Finland.
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.
British journal of cancer·2010
High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytoma.
Endocrine-related cancer·2009
Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours.
Neuropathology and applied neurobiology·2008
Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis.
Clinical and experimental immunology·2004
Angiotensin-induced inflammation and novel approaches to treatment.
Advances in nephrology from the Necker Hospital·2001
Renal fibrosis and the renin-angiotensin system.
Advances in nephrology from the Necker Hospital·2001
What is the optimal blood pressure target in renal patients?
Advances in nephrology from the Necker Hospital·2001
Receptor interacting protein kinase 1 as a potential therapeutic target in inflammatory bowel disease: biological rationale and emerging clinical evidence.
Expert opinion on investigational drugs·2026
Association between systemic immune-inflammation index and mortality in patients admitted to the intensive care unit after urgent or elective major abdominal surgery.
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES·2026
Decoding the gut-brain axis in irritable bowel syndrome: a cross-sectional analysis of anxiety and depression symptoms in constipation and diarrhoea predominant subtypes.
Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina·2026
Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumors.
Neuro-oncology advances·2026